AlphaCore CEO in U.S. News & World Report: The Inflation Reduction Act

The Inflation Reduction Act of 2022 is a widespread bill that covers health care, climate change and taxes, and it also provides many benefits for retirees. To learn more about how the Inflation Reduction Act may impact older Americans, U.S. News & World Report turned to AlphaCore CEO and Founder Dick Pfister, CAIA, for insight.

In addition to potentially slowing inflation, which could provide some relief for seniors living on fixed incomes, the Inflation Reduction Act will also help tackle skyrocketing healthcare prices. One of the bill’s provisions allows the Medicare program to negotiate lower prescription drug prices for seniors on select medications.

“Under the current law, the Medicare program is banned from negotiating drug prices. You have to pay the market price,” Pfister explains. “But with the new law, they actually have to negotiate, and they think that will cause the prices for drugs to drop across the market.”

Another way the Inflation Reduction Act may help relieve America’s retirees is by placing a limit on Medicare out-of-pocket drug expenses. While this provision won’t go into effect until 2025, it is poised to help seniors living on fixed income tackle rising health care and drug costs.

“Prescription drug spending will be capped at $2,000 a year for Medicare beneficiaries,” Pfister tells the publication. “Eventually that will be a good thing, but it’s going to be another three years before that goes into effect.”

Click here to read the entire U.S. News & World Report article.

* Indicates a required field

I am interested in learning about the services of AlphaCore Wealth Advisory LLC, an SEC registered investment adviser. By submitting my name and phone number (which I intend and agree will constitute my electronic signature for the purpose of agreeing to this consent), I expressly consent to be contacted by AlphaCore by phone and/or email, even if the number I provide is on a Federal and/or a state "Do Not Call" list. I represent that I am authorized to provide this consent on behalf of the phone number provided and that such consent is given voluntarily. I understand that I am not required to enter into this consent as a condition of purchasing any property, goods, or services.

This consent is effective unless and until revoked by me, which may be done at any time by emailing, by calling 858-875-4100, or by notifying the representative that calls you.

You may request a copy of this consent or our privacy policy to be emailed or mailed to you by contacting us. Click here to read AlphaCore's privacy policy.

This field is for validation purposes and should be left unchanged.